References
- Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997;95: 252–64
- Witteman J, Grobbee D, Kok FJ, et al. Increased risk of atherosclerosis in women after menopause. Br Med J1989;298:642–4
- Szaajderman OM. Spontaneous premature meno-pause: ischemic heart disease and serum lipids. Lancet 1963;1:962–4
- Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart disease. The Fram-ingham Study. Ann Intern Med 1978;89:157–61
- Van Baal WM, Kooistra T, Stehouwer CD. Cardiovascular disease risk and hormone replace-ment therapy (HRT): a review based on random-ised, controlled studies in postmenopausal women. Curr Med Chem 2000;7:499–517
- Wilcox JG, Hacth IE, Gentzschein E, et al. Endo-thelin levels decrease after oral and nonoral estro-gen in postmenopausal women with increased risk factors. Fertil Steril 1997;67:273–7
- Rosenson RS, Tangney CC, Mosca U. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler Thromb Vasc Biol 1998;18: 1902–5
- Hoibbraaten E, Os I, Slejoflot I, et al. The effects of hormone replacement therapy on hemostatic variables in women with angigraphically verified corornary artery disease: results from the Estrogen in Women with Atherosclerosis Study. Thromb Res 2000;98:19–27
- Walsh BW, Schiff I, Rosner B. Effects of post-menopausal etrogen replacement on the concen-tration and metabolism of lipoproteins. N Engl J Med 1991;325:196–204
- Henderson RE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replace-ment therapy. Arch Intern Med 1991;151:75–8
- Loserdo DW, Kediney M, Kim EA. Variable expression of estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501–10
- Mugge A, Riedel M, Bartan M. Endothelium independent relaxation of human coronary arteries by 17 beta estradiol in vitro. Br J Pharmacol 1993; 104:1033–7
- Rosenberg L, Hennekens CH, Rosner BA, et al. Early menopause and the risk of myocardial infarc-tion. Am J Obstet Gynecol 1981;139:47–51
- Joakmisen 0, Bonaa KH, Stensland-Bugge E, et al. Population-based study of age at menopause and ultrasound assessed atherosclerosis. The Tromso Study. J Clin Epidemiol 2000;53:525–30
- Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 ;18:499–502
- Poli A, Tremoli E, Colombo A, et al. Ultra-s onographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the qauntitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988;70: 253–61
- Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine concentrations and risk of myocardial infarction. J Am Med Assoc 1992;268:877–81
- O'Leary DH, Pollak JF, Wolfion SK, et al., on behalf of the CHS Collaborative Research Group. Use of sonography to evaluate carotid athero-sclerosis in the elderly: the Cardiovascular Health Study. Stroke 1991;22:1155–63
- Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990; 81:33–40
- Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992;2:147–53
- Grudstein F, Stampfer MJ. Estrogen for women at varying risk of coronary disease. Maturitas 1998;30: 19–26
- Varas-Lorenzo C, Garcia-Rodriguez LA, Perez-Gutthann S, et al. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case—control study. Circulation 2000; 101:June 6:2573–8
- Magness RR, Rosenfeld CR. Local and systemic estradio1-17 beta: effect of uterine and systemic vaso dilatation. Am J Physiol1989;256:E536–42
- Redberg RF, Nishino M, McElhinney DB, et al. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease. Am Heart J 2000;139:739–44